Skip To Main Content
Minato City on Muck Rack

Minato City

As seen in: Oxford University Press (OUP), PR Newswire, Biomed Central (BMC), JAMA (The Journal of the American Medical Association), JAMA Internal Medicine Author Interviews, JAMA Oncology, JAMA: Journal of the American Medical Association, KTLA-TV (Los Angeles, CA), KDVR-TV (Denver, CO), WOOD-TV (Grand Rapids, MI) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Minato

Contact Minato, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mental Health Factors in Semaglutide Discontinuation

|
By Michioki Endo, Masahiro Kami, Minato City, Sumoto City
| JAMA Internal Medicine Author Interviews
Mental Health Factors in Semaglutide Discontinuation GLP-1 Receptor Agonist Use and Risk of Suicide Death Peter Ueda, MD, PhD; Jonas Söderling, PhD; Viktor Wintzell, PhD; Henrik Svanström, PhD; Laura Pazzagli, PhD; Björn Eliasson, MD, PhD; Mads Melbye, MD, DrMedSci; Anders Hviid, DrMedSci; Björn Pasternak, MD, PhD Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology Thomas A. Wadden, PhD; Gregory K.
Open in Who Shared Issue with article?

An independent hybrid imaging of Sgr A* from the data in EHT 2017 observations

|
By Minato City, Zhao J.-H, Faber S. M
| Oxford University Press (OUP)
Our independent analysis of the EHT 2017 observational data of Sgr A*, the same data set as used by the EHTC, shows an east–west elongated shape (Fig. 2), which is consistent with previous millimetre-wave observations but distinctly different from the EHTC ring-like structure.
Open in Who Shared Issue with article?

Lepodisiran for Elevated Lipoprotein(a)

|
By Michioki Endo, Kanonji City, Masahiro Kami, Minato City
| JAMA: Journal of the American Medical Association Verified
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a) Steven E. Nissen, MD; Helle Linnebjerg, PhD; Xi Shen, PhD; Kathy Wolski, MPH; Xiaosu Ma, PhD; Shufen Lim, PhD; Laura F. Michael, PhD; Giacomo Ruotolo, MD, PhD; Grace Gribble, MS; Ann Marie Navar, MD, PhD; Stephen J. Nicholls, MBBS, PhD Lepodisiran for Elevated Lipoprotein(a)—Reply Steven E. Nissen, MD; Helle Linnebjerg, PhD; Stephen J.
Open in Who Shared Issue with article?
See all 64 articles